A Phase 2 Study of Yttrium-90 Ibritumomab Tiuxetan (Zevalin) in Patients With Chronic Lymphocytic Leukemia

BACKGROUND: Radioimmunotherapy (RIT) with radiolabeled monoclonal antibodies to CD20 produce a high response rate in patients with relapsed lymphoma. Use of this modality in patients with chronic lymphocytic leukemia (CLL) has been hampered by the extensive marrow involvement seen in patients with C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Jain, Nitin, Wierda, William, Ferrajoli, Alessandra, Wong, Franklin, Lerner, Susan, Keating, Michael, O’Brien, Susan
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4535918/
https://ncbi.nlm.nih.gov/pubmed/19637351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24522
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados